CN104203972A - 丙型流感病毒和疫苗 - Google Patents

丙型流感病毒和疫苗 Download PDF

Info

Publication number
CN104203972A
CN104203972A CN201380012424.3A CN201380012424A CN104203972A CN 104203972 A CN104203972 A CN 104203972A CN 201380012424 A CN201380012424 A CN 201380012424A CN 104203972 A CN104203972 A CN 104203972A
Authority
CN
China
Prior art keywords
influenza virus
separation
nucleic acid
protein
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380012424.3A
Other languages
English (en)
Chinese (zh)
Inventor
R·R·西门逊
E·A·科林
B·M·豪瑟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Newport Laboratories Inc
Original Assignee
Newport Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Laboratories Inc filed Critical Newport Laboratories Inc
Publication of CN104203972A publication Critical patent/CN104203972A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN201380012424.3A 2012-01-27 2013-01-28 丙型流感病毒和疫苗 Pending CN104203972A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/385,004 2012-01-27
US13/385,004 US9278999B2 (en) 2012-01-27 2012-01-27 Influenza C virus and vaccine
PCT/US2013/023441 WO2013112995A1 (en) 2012-01-27 2013-01-28 Influenza c virus and vaccine

Publications (1)

Publication Number Publication Date
CN104203972A true CN104203972A (zh) 2014-12-10

Family

ID=47714564

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380012424.3A Pending CN104203972A (zh) 2012-01-27 2013-01-28 丙型流感病毒和疫苗

Country Status (13)

Country Link
US (1) US9278999B2 (enExample)
EP (1) EP2807184A1 (enExample)
JP (1) JP6257529B2 (enExample)
CN (1) CN104203972A (enExample)
AU (1) AU2013211833B2 (enExample)
BR (1) BR112014018278B1 (enExample)
CA (1) CA2862328C (enExample)
HK (1) HK1201283A1 (enExample)
MX (1) MX360831B (enExample)
NZ (1) NZ629378A (enExample)
PH (1) PH12014501688A1 (enExample)
RU (1) RU2656186C2 (enExample)
WO (1) WO2013112995A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111363855A (zh) * 2020-04-30 2020-07-03 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 一种同时检测a、d型流感病毒的成套试剂、试剂盒及其应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2875041A2 (en) * 2012-07-19 2015-05-27 Zoetis LLC Bovine influenza c virus compositions
AR111770A1 (es) 2017-05-05 2019-08-21 Elanco Us Inc Vacuna para enfermedad respiratoria bovina

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119782A1 (en) * 2000-06-29 2003-06-26 Cham Bill E. Method of treating and preventing infectious diesases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004161781A (ja) * 1992-03-03 2004-06-10 Dai Ichi Seiyaku Co Ltd 経口ワクチン
SG177887A1 (en) * 2006-12-15 2012-02-28 Schering Plough Ltd Method for replicating influenza virus in culture
TW200927928A (en) 2007-09-24 2009-07-01 Nobilon Internat B V Inactivated influenza vaccine
US20090110698A1 (en) * 2007-10-31 2009-04-30 Newport Laboratories, Inc. Method of determining vaccine compliance
RU2428476C1 (ru) * 2010-06-21 2011-09-10 Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) Реассортантный штамм вируса гриппа rn 1/09-swine a(h7n1) для определения антител к нейраминидазе при гриппозной инфекции и вакцинации

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119782A1 (en) * 2000-06-29 2003-06-26 Cham Bill E. Method of treating and preventing infectious diesases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GUO YUANJI ET AL.: "Isolation of influenza C virus from pigs and experimental infection of pigs with influenza C virus", 《J.GEN.VIROL》, vol. 64, no. 1, 1 January 1983 (1983-01-01), pages 177 - 182, XP055064689, DOI: doi:10.1099/0022-1317-64-1-177 *
孟祥金等: "丙型流感病毒的分子生物学和流行病学", 《国外医学》, 25 December 1988 (1988-12-25), pages 245 - 248 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111363855A (zh) * 2020-04-30 2020-07-03 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 一种同时检测a、d型流感病毒的成套试剂、试剂盒及其应用

Also Published As

Publication number Publication date
BR112014018278B1 (pt) 2023-01-17
RU2014134850A (ru) 2016-03-20
RU2656186C2 (ru) 2018-05-31
US9278999B2 (en) 2016-03-08
JP6257529B2 (ja) 2018-01-10
EP2807184A1 (en) 2014-12-03
NZ629378A (en) 2017-06-30
CA2862328C (en) 2021-08-31
WO2013112995A1 (en) 2013-08-01
MX2014009022A (es) 2015-03-03
BR112014018278A2 (pt) 2019-04-02
PH12014501688A1 (en) 2014-10-20
US20130195915A1 (en) 2013-08-01
CA2862328A1 (en) 2013-08-01
MX360831B (es) 2018-11-16
JP2015506949A (ja) 2015-03-05
AU2013211833B2 (en) 2017-09-14
HK1201283A1 (en) 2015-08-28
AU2013211833A2 (en) 2014-09-25
AU2013211833A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
Polatoğlu et al. COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
Killian et al. Simultaneous infection of pigs and people with triple‐reassortant swine influenza virus H1N1 at a US county fair
Tang et al. A multiplex RT-PCR assay for detection and differentiation of avian H3, H5, and H9 subtype influenza viruses and Newcastle disease viruses
CN101633964B (zh) 一种甲型h1n1流感病毒rna检测试剂盒
CN106636472A (zh) 检测禽流感病毒与鸡细小病毒的成套试剂与方法
CN114835778A (zh) 一种h9n2亚型aiv mhc b2限制性表位肽及其应用
TWI702293B (zh) 用於a型流感病毒及b型流感病毒檢測之方法
RU2656186C2 (ru) Вирус гриппа с и вакцина
CN118957165B (zh) 用于检测甲型流感病毒的探针组合、试剂盒及检测方法
Qin et al. Subtyping animal influenza virus with general multiplex RT-PCR and Liquichip high throughput (GMPLex)
RU2361924C1 (ru) Способ обнаружения вируса гриппа а подтипа h5n1
CN102140539A (zh) 甲型h1n1流感病毒检测试剂盒及检测方法
Aileni et al. Biotechnological perspectives to combat the COVID-19 pandemic: precise diagnostics and inevitable vaccine paradigms. Cells. 2022; 11: 1182
Esnault et al. Optimisation of rapid untargeted nanopore DNA virus metagenomics using cell cultures and calves experimentally infected with bovine herpes virus-1
CN112011644A (zh) 甲型流感病毒和乙型流感病毒的检测方法
RU2773654C1 (ru) Способ опосредованного контроля полноты инактивации антигена вируса ящура с применением nested обратно-транскриптазной полимеразной цепной реакции с последующим электрофорезом ампликонов в агарозном геле
KR101339162B1 (ko) 돼지 인플루엔자 바이러스 감염의 예방 또는 치료방법
Kumari et al. Avian influenza: a potential threat to human health
Maharjan Validation of Saliva Biospecimen: an alternative to Nasopharyngeal Swab for detection of SARS-CoV-2 using RT-PCR
Kaore et al. Laboratory diagnosis of novel H1N1 virus
KR20180071655A (ko) 호흡기 바이러스 검출을 위한 프라이머 세트 및 이의 용도
Çarhan et al. How to detect SARS-CoV-2: A brief review about molecular diagnosis techniques.
KR101345787B1 (ko) 신규한 돼지 인플루엔자 바이러스 ａ ｈ1ｎ1 및 그의 용도
RU2532843C2 (ru) Способ диагностики гриппа с
CN116148475A (zh) 一种狂犬病毒中和抗体的elisa检测方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20141210